# Dose-Finding Study of SC411 in Children With Sickle Cell Disease

> **NCT02973360** · PHASE2 · UNKNOWN · sponsor: **Micelle BioPharma Inc** · enrollment: 68 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Docosahexaenoic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02973360
- **Lead sponsor:** Micelle BioPharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-02
- **Primary completion:** 2017-09-26
- **Final completion:** 2022-01-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2019-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973360, "Dose-Finding Study of SC411 in Children With Sickle Cell Disease". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02973360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*